Kalytera Therapeutics Inc KALY.V :
* KALYTERA REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS
* KALYTERA THERAPEUTICS INC QTRLY EARNINGS PER SHARE $0.01
* KALYTERA THERAPEUTICS INC - LARGEST CREDITOR DURING CALENDAR 2018 AND CALENDAR 2019 WILL BE SALZMAN GROUP OF ISRAEL
* KALYTERA THERAPEUTICS INC - BELIEVES IT HAS SUFFICIENT CASH TO FUND ITS CASH OPERATING COSTS BEYOND YEAR-END 2018